Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epacadostat + Durvalumab in Advanced Solid Tumors
NCT02318277Phase 2Completed
- Sponsor
- Incyte
- Start
- Jan 2015
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of epacadostat in solid tumor, head and neck cancer (HNC), lung cancer, urothelial carcinoma (UC), sponsored by Incyte. Started Jan 2015; status: completed.
02
Drugs
epacadostat
03
Conditions
solid tumorhead and neck cancer (HNC)lung cancerurothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT02318277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02318277.